Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch. …

An Oklahoma judge has declined to approve a proposed $85 million settlement between the state and Teva Pharmaceuticals (TEVA) until he is assured it complies with a new law targeting such deals, the Associated Press writes. Cleveland County Judge Thad Balkman ordered attorneys for both the state and Teva to file additional paperwork before he approves the settlement. Concerned about how the state’s $270 million settlement with Purdue Pharmaceuticals was structured, the Republican-led legislature passed a law directing any settlement funds directly into the state treasury.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • And here we are now, in Florida and in the national debate, where instead of using science / public health data to make the argument – “DeSantis has insisted his close relationship with President Trump would help win over skeptical federal officials …”

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy